Brainard Diana
SEC CIK 1818070 · EDGAR
BoughtSold
Most active insiders at KLRS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| 2 | AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| 3 | Hagen Brett R | CAO | — | $12.9K |
Brainard Diana made no open-market trades at KLRS in the last 12 months.
Transactions 37
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | 2024-11-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.55 | -8,706 | 723.4K | -1% | -$4,788 | |
| 2024-11-06 | 2024-11-05 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.86 | -10.6K | 732.1K | -1% | -$9,124 | |
| 2024-10-23 | 2024-10-21 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.78 | -9,752 | 742.7K | -1% | -$7,607 | |
| 2024-10-04 | 2024-10-03 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.81 | -1,493 | 752.4K | -0.2% | -$1,209 | |
| 2024-08-22 | 2024-08-20 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.74 | -5,390 | 753.9K | -0.7% | -$3,989 | |
| 2024-08-20 | 2024-08-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.76 | -3,091 | 759.3K | -0.4% | -$2,349 | |
| 2024-08-07 | 2024-08-05 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.73 | -10.8K | 762.4K | -1% | -$7,918 | |
| 2024-07-23 | 2024-07-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.75 | -9,731 | 773.3K | -1% | -$7,298 | |
| 2024-07-03 | 2024-07-02 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.72 | -1,489 | 783.0K | -0.2% | -$1,072 | |
| 2024-05-23 | 2024-05-21 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.79 | -5,149 | 784.5K | -0.7% | -$4,068 | |
| 2024-05-21 | 2024-05-17 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.75 | -3,075 | 789.6K | -0.4% | -$2,306 | |
| 2024-05-07 | 2024-05-03 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.8 | -10.2K | 792.7K | -1% | -$8,192 | |
| 2024-04-23 | 2024-04-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.75 | -9,601 | 802.9K | -1% | -$7,201 | |
| 2024-04-04 | 2024-04-02 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.77 | -1,533 | 812.5K | -0.2% | -$1,180 | |
| M | 2024-02-22 | 2024-02-20+ | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.7062 | -8,252 | 819.2K | -1.0% | -$5,828 |
| 2024-02-06 | 2024-02-05 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.67 | -41.4K | 822.3K | -5% | -$27.8K | |
| 2024-01-25 | 2024-01-23 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.67 | -9,500 | 863.7K | -1% | -$6,365 | |
| 2024-01-08 | 2024-01-04 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $0.64 | -1,664 | 873.2K | -0.2% | -$1,065 | |
| M | 2023-11-21 | 2023-11-17+ | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $1.67 | -7,071 | 879.3K | -0.8% | -$11.8K |
| 2023-10-23 | 2023-10-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $1.58 | -8,581 | 882.0K | -1.0% | -$13.6K | |
| 2023-10-05 | 2023-10-03 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $1.98 | -1,325 | 890.6K | -0.1% | -$2,624 | |
| M | 2023-08-21 | 2023-08-17+ | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $2.58 | -15.4K | 895.9K | -2% | -$39.7K |
| 2023-07-21 | 2023-07-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $3.56 | -8,342 | 907.3K | -0.9% | -$29.7K | |
| 2023-07-06 | 2023-07-05 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $3.05 | -5,275 | 915.6K | -0.6% | -$16.1K | |
| 2023-05-19 | 2023-05-18 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $4.21 | -4,536 | 916.6K | -0.5% | -$19.1K | |
| 2023-04-21 | 2023-04-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $3.71 | -8,408 | 921.2K | -0.9% | -$31.2K | |
| 2023-02-23 | 2023-02-21 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $6.63 | -5,122 | 929.6K | -0.5% | -$34.0K | |
| D | 2023-02-03 | 2023-02-02 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +332.5K | 935.0K | +55% | $0 |
| 2023-01-23 | 2023-01-19 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $5.08 | -34.4K | 601.6K | -5% | -$174.9K | |
| 2022-11-21 | 2022-11-18 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $7.27 | -4,515 | 633.0K | -0.7% | -$32.8K | |
| D | 2022-09-20 | 2022-09-16 | NKTR | NEKTAR THERAPEUTICS | Brainard Diana | Dir | A - Grant | $0.00 | +10.2K | 28.6K | +56% | $0 |
| 2022-08-19 | 2022-08-18 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $7.76 | -4,564 | 637.5K | -0.7% | -$35.4K | |
| 2022-08-17 | 2022-08-16 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +100.0K | 642.1K | +18% | $0 | |
| D | 2022-07-06 | 2022-07-01 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +48.1K | 542.1K | +10% | $0 |
| 2022-05-23 | 2022-05-18 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | S - Sale | $4.33 | -29.1K | 492.2K | -6% | -$126.2K | |
| D | 2022-04-04 | 2022-01-18 | KLRS | Kalaris Therapeutics, Inc. | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +315.0K | 521.3K | +153% | $0 |
| D | 2021-11-15 | 2021-11-11 | NKTR | NEKTAR THERAPEUTICS | Brainard Diana | Dir | A - Grant | $0.00 | +18.4K | 18.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations